Why are mineralocorticoid receptor antagonists cardioprotective?

le Chai, Wenxia, Danser, A. H. Jan
Foilsithe 2006

Juxtaglomerular Cell Phenotypic Plasticity

le Martini, Alexandre Góes, Danser, A. H. Jan
Foilsithe in High Blood Press Cardiovasc Prev (2017)

Revisiting the Brain Renin-Angiotensin System—Focus on Novel Therapies

le Ren, Liwei, Lu, Xifeng, Danser, A. H. Jan
Foilsithe in Curr Hypertens Rep (2019)

Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?

le Sun, Yuan, Lu, Xifeng, Danser, A. H. Jan
Foilsithe in Curr Hypertens Rep (2020)

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers

le Danser, A.H. Jan, Epstein, Murray, Batlle, Daniel
Foilsithe in Hypertension (2020)

Is there an internal cardiac renin-angiotensin system?

le Danser, A H Jan, Schalekamp, Maarten A D H
Foilsithe 1996

Local Angiotensin Generation and AT(2) Receptor Activation

le Esch, Joep H.M. Van, Danser, A.H. Jan
Foilsithe in Frontiers in Research of the Renin-Angiotensin System on Human Disease (2007)

The (pro)renin receptor. A decade of research: what have we learned?

le Krop, Manne, Lu, Xifeng, Danser, A.H. Jan, Meima, Marcel E.
Foilsithe 2012

Renal Angiotensin-Converting Enzyme Upregulation: A Prerequisite for Nitric Oxide Synthase Inhibition–Induced Hypertension?

le Roksnoer, Lodi C.W., Hoorn, Ewout J., Danser, A.H. Jan
Foilsithe in J Am Soc Nephrol (2014)

L-NAME-resistant bradykinin-induced relaxation in porcine coronary arteries is NO-dependent: effect of ACE inhibition

le Danser, A H Jan, Tom, Beril, de Vries, René, Saxena, Pramod R
Foilsithe 2000

Response to “Is High Prorenin Level Related to Relative Aldosterone Excess?”

le Tu, Wanzhu, Eckert, George J., Pratt, J. Howard, Danser, A.H. Jan
Foilsithe in Am J Hypertens (2013)

Headache medication and the COVID-19 pandemic

le MaassenVanDenBrink, Antoinette, de Vries, Tessa, Danser, A. H. Jan
Foilsithe in J Headache Pain (2020)

Modulation of α(2C) adrenergic receptor temperature-sensitive trafficking by HSP90

le Filipeanu, Catalin M., de Vries, René, Danser, A.H. Jan, Kapusta, Daniel R.
Foilsithe 2010

From ARB to ARNI in Cardiovascular Control

le Uijl, Estrellita, Roksnoer, Lodi C. W., Hoorn, Ewout J., Danser, A. H. Jan
Foilsithe in Curr Hypertens Rep (2016)

Prorenin anno 2008

le Danser, A. H. Jan, Batenburg, Wendy W., van Esch, Joep H. M., Krop, Manne
Foilsithe 2008

The emerging role of endothelin-1 in the pathogenesis of pre-eclampsia

le Saleh, Langeza, Verdonk, Koen, Visser, Willy, van den Meiracker, Anton H., Danser, A. H. Jan
Foilsithe in Ther Adv Cardiovasc Dis (2016)

Aspirin for the prevention and treatment of pre‐eclampsia: A matter of COX‐1 and/or COX‐2 inhibition?

le Mirabito Colafella, Katrina M., Neuman, Rugina I., Visser, Willy, Danser, A. H. Jan, Versmissen, Jorie
Foilsithe in Basic Clin Pharmacol Toxicol (2019)

Renal responses to three types of renin-angiotensin system blockers in patients with diabetes mellitus: a need for higher doses in diabetics?

le Hollenberg, Norman K., Fisher, Naomi DL, Nussberger, Juerg, Moukarbel, George V., Barkoudah, Ebrahim, Danser, A.H. Jan
Foilsithe in J Hypertens (2011)

Effects of Renin-Angiotensin Inhibition on ACE2 and TMPRSS2 Expression: Insights into COVID-19

le Wu, Congqing, Ye, Dien, Mullick, Adam E., Li, Zhenyu, Danser, A.H. Jan, Daugherty, Alan, Lu, Hong S.
Foilsithe in bioRxiv (2020)

Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19

le Wu, Congqing, Ye, Dien, Mullick, Adam E., Li, Zhenyu, Danser, A.H. Jan, Daugherty, Alan, Lu, Hong S.
Foilsithe in Hypertension (2020)